# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
100, Journal, 0, 13, "Diabetes Care", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasJournal> \"Diabetes Care\"."
0, PublicationYear, 16, 20, "2005", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasPublicationYear> \"2005\"."
199, Title, 48, 183, "Comparison of basal insulin added to oral agents versus twice - daily premixed insulin as initial insulin therapy for type 2 diabetes .", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasTitle> \"Comparison of basal insulin added to oral agents versus twice - daily premixed insulin as initial insulin therapy for type 2 diabetes .\"."
127, Insulin, 68, 75, "insulin", "", 
85, OralAntidiabeticAgent, 82, 96, "to oral agents", "", 
19, Frequency, 104, 117, "twice - daily", "", 
39003, PremixedInsulin, 118, 134, "premixed insulin", "", 
86, Insulin, 146, 153, "insulin", "", 
12, Type2Diabetes, 166, 181, "type 2 diabetes", "", 
1, Author, 184, 192, "Janka HU", "", 
2, Author, 201, 208, "Plewe G", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasAuthor> \"Plewe G\"."
3, Author, 211, 220, "Riddle MC", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasAuthor> \"Riddle MC\"."
4, Author, 223, 240, "Kliebe - Frisch C", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasAuthor> \"Kliebe - Frisch C\"."
5, Author, 243, 256, "Schweitzer MA", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasAuthor> \"Schweitzer MA\"."
6, Author, 259, 277, "Yki - J ä rvinen H", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasAuthor> \"Yki - J ä rvinen H\"."
8, Germany, 413, 420, "Germany", "", "<http://ctro/data#Population_30949> <http://ctro/data#hasCountry> <http://ctro/data#Germany>."
200, ObjectiveDescription, 608, 823, "To compare the efficacy and safety of adding once - daily basal insulin versus switching to twice - daily premixed insulin in type 2 diabetic patients insufficiently controlled by oral antidiabetic agents ( OADs ) .", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasObjectiveDescription> \"To compare the efficacy and safety of adding once - daily basal insulin versus switching to twice - daily premixed insulin in type 2 diabetic patients insufficiently controlled by oral antidiabetic agents ( OADs ) .\"."
20, Frequency, 653, 665, "once - daily", "", 
131, Insulin, 672, 679, "insulin", "", 
21, Frequency, 700, 713, "twice - daily", "", 
39004, PremixedInsulin, 714, 730, "premixed insulin", "", 
9, Precondition, 734, 821, "type 2 diabetic patients insufficiently controlled by oral antidiabetic agents ( OADs )", "", "<http://ctro/data#Population_30949> <http://ctro/data#hasPrecondition> \"type 2 diabetic patients insufficiently controlled by oral antidiabetic agents ( OADs )\"."
13, Type2Diabetes, 734, 749, "type 2 diabetic", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
87, OralAntidiabeticAgent, 788, 812, "oral antidiabetic agents", "", 
88, OralAntidiabeticAgent, 815, 819, "OADs", "", 
18, Duration, 859, 868, "24 - week", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasCTduration> \"24 - week\"."
155, CTDesign, 871, 884, "multinational", "", "<http://ctro/data#CTDesign_30927> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign>. <http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_30927>."
15, Multicenter, 887, 898, "multicenter", "", 
16, OpenLabel, 901, 905, "open", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
17, Parallel, 908, 916, "parallel", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
10, NumberPatientsCT, 940, 943, "371", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasNumberPatientsCT> \"371\"."
117, Precondition, 944, 1117, "insulin - naive patients with poor glycemic control ( fasting blood glucose [ FBG ] > / = 120 mg / dl , HbA ( 1c ) 7 . 5 - 10 . 5 % ) on OADs ( sulfonylurea plus metformin )", "", "<http://ctro/data#Population_30949> <http://ctro/data#hasPrecondition> \"insulin - naive patients with poor glycemic control ( fasting blood glucose [ FBG ] > / = 120 mg / dl , HbA ( 1c ) 7 . 5 - 10 . 5 % ) on OADs ( sulfonylurea plus metformin )\"."
202, FastingBloodGlucose, 998, 1019, "fasting blood glucose", "", 
203, FastingBloodGlucose, 1022, 1025, "FBG", "", 
22, Mg_per_deciliter, 1038, 1045, "mg / dl", "", 
23, HbA1c, 1048, 1058, "HbA ( 1c )", "", 
24, Percentage, 1074, 1075, "%", "", 
89, OralAntidiabeticAgent, 1081, 1085, "OADs", "", 
80, Sulfonylureas, 1088, 1100, "sulfonylurea", "", 
81, Metformin, 1106, 1115, "metformin", "", 
25, Randomized, 1123, 1133, "randomized", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
26, Frequency, 1137, 1149, "once - daily", "", "<http://ctro/data#Intervention_31006> <http://ctro/data#hasFrequency> \"once - daily\"."
27, Morning, 1150, 1157, "morning", "", "<http://ctro/data#Intervention_31006> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Morning>."
28, InsulinGlargine, 1158, 1174, "insulin glargine", "", "<http://ctro/data#Medication_31018> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine>."
29, Glimepiride, 1180, 1191, "glimepiride", "", "<http://ctro/data#Medication_91581> <http://ctro/data#hasDrug> <http://ctro/data#Glimepiride>."
30, Metformin, 1196, 1205, "metformin", "", "<http://ctro/data#Medication_91588> <http://ctro/data#hasDrug> <http://ctro/data#Metformin>."
31, InsulinGlargine, 1208, 1216, "glargine", "", 
90, OralAntidiabeticAgent, 1222, 1225, "OAD", "", 
39005, NPH/regular70/30, 1234, 1271, "30 % regular / 70 % human NPH insulin", "", "<http://ctro/data#Medication_31039> <http://ctro/data#hasDrug> <http://ctro/data#NPH/regular70/30>."
39006, NPH/regular70/30, 1274, 1281, "70 / 30", "", 
33, Frequency, 1284, 1295, "twice daily", "", "<http://ctro/data#Intervention_31012> <http://ctro/data#hasFrequency> \"twice daily\"."
91, OralAntidiabeticAgent, 1304, 1308, "OADs", "", 
51227, DoseDescription, 1330, 1451, "titrated to target FBG < / = 100 mg / dl ( both insulins ) and predinner blood glucose < / = 100 mg / dl ( 70 / 30 only )", "", "<http://ctro/data#Medication_31018> <http://ctro/data#hasDoseDescription> \"titrated to target FBG < / = 100 mg / dl ( both insulins ) and predinner blood glucose < / = 100 mg / dl ( 70 / 30 only )\". <http://ctro/data#Medication_31039> <http://ctro/data#hasDoseDescription> \"titrated to target FBG < / = 100 mg / dl ( both insulins ) and predinner blood glucose < / = 100 mg / dl ( 70 / 30 only )\"."
134, FastingPlasmaGlucose_target, 1349, 1370, "FBG < / = 100 mg / dl", "", 
34, Mg_per_deciliter, 1363, 1370, "mg / dl", "", 
83, Insulin, 1378, 1386, "insulins", "", 
51226, RelativeTime, 1393, 1402, "predinner", "", 
135, FastingPlasmaGlucose_target, 1393, 1434, "predinner blood glucose < / = 100 mg / dl", "", 
36, Mg_per_deciliter, 1427, 1434, "mg / dl", "", 
39007, NPH/regular70/30, 1437, 1444, "70 / 30", "", 
35, MeasurementDevice, 1460, 1495, "weekly forced - titration algorithm", "", 
195, Mean, 1508, 1512, "Mean", "", "<http://ctro/data#Mean_30960> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_30958> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_30960>."
37, HbA1c, 1513, 1523, "HbA ( 1c )", "", 
38, Reduction, 1585, 1591, "1 . 64", "", "<http://ctro/data#Outcome_31046> <http://ctro/data#hasChangeValue> \"1 . 64\"."
39, Reduction, 1599, 1605, "1 . 31", "", "<http://ctro/data#Outcome_31073> <http://ctro/data#hasChangeValue> \"1 . 31\"."
40, Percentage, 1606, 1607, "%", "", "<http://ctro/data#Endpoint_30958> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
41, PvalueDiff, 1610, 1622, "P = 0 . 0003", "", "<http://ctro/data#DiffBetweenGroups_31100> <http://ctro/data#hasPvalueDiff> \"P = 0 . 0003\"."
42, HbA1c_target, 1653, 1677, "HbA ( 1c ) < / = 7 . 0 %", "", "<http://ctro/data#Endpoint_30963> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target>."
43, Percentage, 1676, 1677, "%", "", 
44, NocturnalHypoglycemia, 1696, 1718, "nocturnal hypoglycemia", "", "<http://ctro/data#Endpoint_30968> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#NocturnalHypoglycemia>."
60, PercentageAffected, 1721, 1727, "45 . 5", "", 
61, PercentageAffected, 1733, 1739, "28 . 6", "", "<http://ctro/data#Outcome_31136> <http://ctro/data#hasPercentageAffected> \"28 . 6\"."
45, PvalueDiff, 1744, 1756, "P = 0 . 0013", "", "<http://ctro/data#DiffBetweenGroups_31163> <http://ctro/data#hasPvalueDiff> \"P = 0 . 0013\"."
46, InsulinGlargine, 1764, 1772, "glargine", "", 
94, OralAntidiabeticAgent, 1778, 1781, "OAD", "", 
39008, NPH/regular70/30, 1792, 1799, "70 / 30", "", 
205, FastingBloodGlucose, 1814, 1817, "FBG", "", "<http://ctro/data#Endpoint_30973> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingBloodGlucose>."
48, InsulinGlargine, 1844, 1852, "glargine", "", 
95, OralAntidiabeticAgent, 1858, 1861, "OAD", "", 
196, Mean, 1873, 1877, "mean", "", "<http://ctro/data#Mean_30975> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_30973> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_30975>."
162, DiffGroupAbsValue, 1889, 1893, "- 17", "", "<http://ctro/data#DiffBetweenGroups_31226> <http://ctro/data#hasDiffGroupAbsValue> \"- 17\"."
50, Mg_per_deciliter, 1894, 1901, "mg / dl", "", "<http://ctro/data#Endpoint_30973> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Mg_per_deciliter>."
164, DiffGroupAbsValue, 1904, 1911, "- 0 . 9", "", 
53, Millimoles_per_litre, 1912, 1920, "mmol / l", "", 
166, PvalueDiff, 1925, 1937, "P < 0 . 0001", "", "<http://ctro/data#DiffBetweenGroups_31226> <http://ctro/data#hasPvalueDiff> \"P < 0 . 0001\"."
209, FastingBloodGlucose_target, 1968, 1996, "target FBG < / = 100 mg / dl", "", "<http://ctro/data#Endpoint_30978> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingBloodGlucose_target>."
54, Mg_per_deciliter, 1989, 1996, "mg / dl", "", 
55, InsulinGlargine, 2002, 2010, "glargine", "", 
96, OralAntidiabeticAgent, 2016, 2019, "OAD", "", 
39009, NPH/regular70/30, 2030, 2037, "70 / 30", "", 
57, PercentageAffected, 2040, 2046, "31 . 6", "", "<http://ctro/data#Outcome_31235> <http://ctro/data#hasPercentageAffected> \"31 . 6\"."
58, PercentageAffected, 2052, 2058, "15 . 0", "", "<http://ctro/data#Outcome_31262> <http://ctro/data#hasPercentageAffected> \"15 . 0\"."
59, PvalueDiff, 2063, 2075, "P = 0 . 0001", "", "<http://ctro/data#DiffBetweenGroups_31289> <http://ctro/data#hasPvalueDiff> \"P = 0 . 0001\". <http://ctro/data#DiffBetweenGroups_31352> <http://ctro/data#hasPvalueDiff> \"P = 0 . 0001\"."
62, InsulinGlargine, 2080, 2088, "Glargine", "", 
97, OralAntidiabeticAgent, 2094, 2097, "OAD", "", 
63, Hypoglycemia, 2127, 2148, "hypoglycemic episodes", "", "<http://ctro/data#Endpoint_30983> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia>."
39010, NPH/regular70/30, 2154, 2161, "70 / 30", "", 
197, Mean, 2173, 2177, "mean", "", "<http://ctro/data#Mean_30985> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_30983> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_30985>."
65, NumberAffected, 2178, 2184, "4 . 07", "", "<http://ctro/data#Outcome_31298> <http://ctro/data#hasNumberAffected> \"4 . 07\"."
66, NumberAffected, 2190, 2196, "9 . 87", "", "<http://ctro/data#Outcome_31325> <http://ctro/data#hasNumberAffected> \"9 . 87\"."
177, BioAndMedicalUnit, 2197, 2213, "/ patient - year", "", "<http://ctro/data#BioAndMedicalUnit_30986> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_30983> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_30986>."
67, PvalueDiff, 2216, 2228, "P < 0 . 0001", "", 
190, ConclusionComment, 2247, 2490, "Initiating insulin treatment by adding basal insulin glargine once daily to glimepiride plus metformin treatment was safer and more effective than beginning twice - daily injections of 70 / 30 and discontinuing OADs in type 2 diabetic patients", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasConclusionComment> \"Initiating insulin treatment by adding basal insulin glargine once daily to glimepiride plus metformin treatment was safer and more effective than beginning twice - daily injections of 70 / 30 and discontinuing OADs in type 2 diabetic patients\"."
68, Insulin, 2258, 2265, "insulin", "", 
69, InsulinGlargine, 2292, 2308, "insulin glargine", "", 
70, Frequency, 2309, 2319, "once daily", "", 
71, Glimepiride, 2323, 2334, "glimepiride", "", 
72, Metformin, 2340, 2349, "metformin", "", 
73, Frequency, 2404, 2417, "twice - daily", "", 
39011, NPH/regular70/30, 2432, 2439, "70 / 30", "", 
98, OralAntidiabeticAgent, 2458, 2462, "OADs", "", 
14, Type2Diabetes, 2466, 2481, "type 2 diabetic", "", 
191, ConclusionComment, 2491, 2526, "inadequately controlled with OADs .", "", "<http://ctro/data#ClinicalTrial_30921> <http://ctro/data#hasConclusionComment> \"inadequately controlled with OADs .\"."
99, OralAntidiabeticAgent, 2520, 2524, "OADs", "", 
7, PMID, 2575, 2583, "15677775", "", "<http://ctro/data#Publication_30909> <http://ctro/data#hasPMID> \"15677775\"."
